Jason Lettmann - CHIEF EXECUTIVE OFFICER, Director at ALX ONCOLOGY HOLDINGS INC

Insider Transactions and Holdings

Entity Type
Individual
Role
CHIEF EXECUTIVE OFFICER, Director
Issuer Symbol
ALXO on Nasdaq
All Insider Reports
All Insider Reports

Jason Lettmann - trading volume in the past year for ALX ONCOLOGY HOLDINGS INC

Holdings reported by Jason Lettmann for ALX ONCOLOGY HOLDINGS INC

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 305,920 $694,438 $2.27 17 Feb 2026 Direct
Stock option (right to buy) 912,000 26 Jan 2026 Direct Common Stock
Employee Stock Option (right to buy) 597,500 14 Oct 2025 Direct Common Stock

Transactions reported by Jason Lettmann for ALX ONCOLOGY HOLDINGS INC

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.